We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Crystal Structure of Transport Protein Links Structure to Function

By Biotechdaily staff writers
Posted on 15 Aug 2003
Researchers using advanced x-ray crystallography techniques have produced a high-resolution three-dimensional crystal structure for lactose permease, a member of the Major Facilitator Superfamily (MFS) of transport proteins.

Lactose permease is the primary mover of lactose through the membrane of Escherichia coli, and is a model for similar transport proteins in other organisms. By applying the latest x-ray crystallography methods, investigators at Imperial College (London, UK; www.imperial.ac.uk) and the University of California, Los Angeles (USA; www.ucla.edu) have produced the crystal structure at 3.5 angstroms for the E coli lactose permease.

They reported in the August 1, 2003, issue of Science that the molecule was composed of N- and C-terminal domains, each with six transmembrane helices, symmetrically positioned within the permease. A large internal hydrophilic cavity open to the cytoplasmic side represented the inward-facing conformation of the transporter. The structure with a bound lactose homolog, beta-D-galactopyranosyl-1-thio-beta-D-galactopyranoside, revealed the sugar-binding site in the cavity, and residues that play major roles in substrate recognition and proton translocation were identified.

Senior author Professor So Iwata of the laboratory for membrane protein crystallography at Imperial College explained, "The three-dimensional structure of lactose permease gives us our first real picture of how the family of enzymes work. Membrane transport proteins play major roles in depression, stroke and diabetes. Unraveling their structure is critical not only for understanding how we function but also to improve drug design.”





Related Links:
Imperial College
University of California, Los Angeles

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Multi-Chamber Washer-Disinfector
WD 390

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
15 Aug 2003  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
15 Aug 2003  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
15 Aug 2003  |   BioResearch